Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vinpocetine manufacturers

26 products found

Filters

26 products found

vinpocetine

Tablets 5mg, 10mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16186
It is a national manufacturer of pharmaceuticals and dietary supplements with a 50-year track record on the market in Central Europe. The company's principal goal is to expand its business, but it also has a secondary goal of expanding its business in Central and Eastern Europe.

Manufacturer usually replies in 4 days

vinpocetine

Tablets 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

vinpocetine

Tablets 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 8 days

Want to see all 26 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Vinpocetine:

Vinpocetine, also known by the name ethyl apovincaminate, is a synthetic derivative of the vinca alkaloid vincamine. Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor. A lesser periwinkle (evergreen plant of the genus Vinca). While originally termed a dietary supplement, in recent years vinpocetine has been produced by pharmaceutical products manufacturers for clinical use in Europe. Where it is used as a medication or treatment of cerebrovascular disorders such as stroke and dementia. It and similar drugs have however not been given regulatory approval in the United States for sale on the medical marketplace. The sale of vinpocetine as a supplement is banned in Australia, New Zealand, and Canada due to "potential harmful nootropic characteristics" and evidence of its beneficial properties regarding either dementia or stroke therapies is disputed. Regardless, due to the existing support in certain regions, vinpocetine manufactures and vinpocetine suppliers produce it for sale. Where it can commonly be found on the global marketplace ready for order from distributors at wholesale for a variety of cost and price points.

Method of action of Vinpocetine:

The specifics of vinpocetine action remains unknown. However, the mechanism of action is postulated to involve three potential effects. The blockage of sodium channels, reduction of cellular calcium influx, and the modulation of antioxidant activity.

Form and dosage of vinpocetine:

As with all pharmaceutical products and drugs, the final form and packaging of vinpocetine is dependent on the manufacturers and suppliers, as well as the specific distributors and order. Due to the nature of vinpocetine, it can commonly be found for wholesale and sale in forms including tablets, capsules, concentrate for solution for infusion, solution for injection, vials, and ampules. Dosing is depending on the individual and the specific indication being treated. For further information please refer to an accredited medical professional or refer to the manufacturers’ literature.

Vinpocetine on Pipelinepharma:

Currently, at the time of writing, we have found 18 verified vinpocetine manufacturers and vinpocetine suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries such as the European Union, Ukraine, and Belarus. Each company and its pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of vinpocetine and how to buy:

The cost of vinpocetine is highly dependent on numerous factors such as form, purity, intention, location, and market. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find newly qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation